Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Ozzy Osbourne has never been one to back down from a fight. But in recent years, the Black Sabbath frontman, now 76, has ...

On the increasingly wary side is Macro Tourist blog author and former institutional trader Kevin Muir, who in our call of the ...

The process allows the children to get most of their DNA from their parents, while also avoiding mitochondrial diseases their mother might otherwise have passed on.

It is trying to treat a devastating lifelong disease by fixing it at its source. We are able to fix the actual genetic ...

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...

Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...

The drastic cost-cutting move follows the deaths of two teenagers that forced the company to restrict usage of its gene ...

Boyang Wang on Targeting Underfunded Longevity Projects SINGAPORE, SG / ACCESS Newswire / July 16, 2025 / Immortal Dragons, a ...

Sarepta Therapeutics will cut 500 jobs and add a serious warning on the label of its muscle-disorder gene therapy Elevidys, the drugmaker said on Wednesday, following the recent deaths of two patients ...

Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...